 | • レポートコード：MRC23Q38869 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の静脈血栓塞栓症予防市場について調査・分析し、世界の静脈血栓塞栓症予防市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（下肢、上肢）、用途別セグメント分析（病院、クリニック、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Arjo、Encompass Group、Talley Group、MEGO AFEK、Zenith Technical Innovations、Normatec、Bio Compression Systems、ThermoTek USAなどが含まれています。世界の静脈血栓塞栓症予防市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、静脈血栓塞栓症予防市場規模を推定する際に考慮しました。本レポートは、静脈血栓塞栓症予防の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、静脈血栓塞栓症予防に関するビジネス上の意思決定に役立てることを目的としています。 ・静脈血栓塞栓症予防市場の概要 - 製品の定義 - 静脈血栓塞栓症予防のタイプ別セグメント - 世界の静脈血栓塞栓症予防市場規模：タイプ別分析（下肢、上肢） - 静脈血栓塞栓症予防の用途別セグメント - 世界の静脈血栓塞栓症予防市場規模：用途別分析（病院、クリニック、その他） - 世界の静脈血栓塞栓症予防市場規模予測（2018年-2029年） - 静脈血栓塞栓症予防の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - 静脈血栓塞栓症予防市場の競争状況およびトレンド ・静脈血栓塞栓症予防の地域別市場規模 - 北米の静脈血栓塞栓症予防市場規模（2018年-2029年） - アメリカの静脈血栓塞栓症予防市場規模（2018年-2029年） - ヨーロッパの静脈血栓塞栓症予防市場規模（2018年-2029年） - アジア太平洋の静脈血栓塞栓症予防市場規模（2018年-2029年） - 中国の静脈血栓塞栓症予防市場規模（2018年-2029年） - 日本の静脈血栓塞栓症予防市場規模（2018年-2029年） - 韓国の静脈血栓塞栓症予防市場規模（2018年-2029年） - インドの静脈血栓塞栓症予防市場規模（2018年-2029年） - オーストラリアの静脈血栓塞栓症予防市場規模（2018年-2029年） - 中南米の静脈血栓塞栓症予防市場規模（2018年-2029年） - 中東・アフリカの静脈血栓塞栓症予防市場規模（2018年-2029年） ・タイプ別セグメント：下肢、上肢 - 世界の静脈血栓塞栓症予防のタイプ別販売量（2018年-2023年） - 世界の静脈血栓塞栓症予防のタイプ別売上（2018年-2023年） - 世界の静脈血栓塞栓症予防のタイプ別価格 ・用途別セグメント：病院、クリニック、その他 - 世界の静脈血栓塞栓症予防の用途別販売量（2018年-2023年） - 世界の静脈血栓塞栓症予防の用途別売上（2018年-2023年） - 世界の静脈血栓塞栓症予防の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Arjo、Encompass Group、Talley Group、MEGO AFEK、Zenith Technical Innovations、Normatec、Bio Compression Systems、ThermoTek USA ・産業チェーンと販売チャネルの分析 - 静脈血栓塞栓症予防産業チェーン分析 - 静脈血栓塞栓症予防の主要原材料 - 静脈血栓塞栓症予防の販売チャネル - 静脈血栓塞栓症予防のディストリビューター - 静脈血栓塞栓症予防の主要顧客 ・静脈血栓塞栓症予防市場ダイナミクス - 静脈血栓塞栓症予防の業界動向 - 静脈血栓塞栓症予防市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Venous Thromboembolism Prophylaxis market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Venous Thromboembolism Prophylaxis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Venous Thromboembolism Prophylaxis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Venous Thromboembolism Prophylaxis include Arjo, Encompass Group, Talley Group, MEGO AFEK, Zenith Technical Innovations, Normatec, Bio Compression Systems and ThermoTek USA, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Venous Thromboembolism Prophylaxis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Venous Thromboembolism Prophylaxis.
The Venous Thromboembolism Prophylaxis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Venous Thromboembolism Prophylaxis market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Venous Thromboembolism Prophylaxis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Arjo
Encompass Group
Talley Group
MEGO AFEK
Zenith Technical Innovations
Normatec
Bio Compression Systems
ThermoTek USA
Segment by Type
Lower Extremity
Upper Extremity
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Venous Thromboembolism Prophylaxis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Venous Thromboembolism Prophylaxis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Venous Thromboembolism Prophylaxis Market Overview
1.1 Product Overview and Scope of Venous Thromboembolism Prophylaxis
1.2 Venous Thromboembolism Prophylaxis Segment by Type
1.2.1 Global Venous Thromboembolism Prophylaxis Market Value Comparison by Type (2023-2029)
1.2.2 Lower Extremity
1.2.3 Upper Extremity
1.3 Venous Thromboembolism Prophylaxis Segment by Application
1.3.1 Global Venous Thromboembolism Prophylaxis Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Venous Thromboembolism Prophylaxis Market Size Estimates and Forecasts
1.4.1 Global Venous Thromboembolism Prophylaxis Revenue 2018-2029
1.4.2 Global Venous Thromboembolism Prophylaxis Sales 2018-2029
1.4.3 Global Venous Thromboembolism Prophylaxis Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Venous Thromboembolism Prophylaxis Market Competition by Manufacturers
2.1 Global Venous Thromboembolism Prophylaxis Sales Market Share by Manufacturers (2018-2023)
2.2 Global Venous Thromboembolism Prophylaxis Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Venous Thromboembolism Prophylaxis Average Price by Manufacturers (2018-2023)
2.4 Global Venous Thromboembolism Prophylaxis Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Venous Thromboembolism Prophylaxis, Product Type & Application
2.7 Venous Thromboembolism Prophylaxis Market Competitive Situation and Trends
2.7.1 Venous Thromboembolism Prophylaxis Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Venous Thromboembolism Prophylaxis Players Market Share by Revenue
2.7.3 Global Venous Thromboembolism Prophylaxis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Venous Thromboembolism Prophylaxis Retrospective Market Scenario by Region
3.1 Global Venous Thromboembolism Prophylaxis Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Venous Thromboembolism Prophylaxis Global Venous Thromboembolism Prophylaxis Sales by Region: 2018-2029
3.2.1 Global Venous Thromboembolism Prophylaxis Sales by Region: 2018-2023
3.2.2 Global Venous Thromboembolism Prophylaxis Sales by Region: 2024-2029
3.3 Global Venous Thromboembolism Prophylaxis Global Venous Thromboembolism Prophylaxis Revenue by Region: 2018-2029
3.3.1 Global Venous Thromboembolism Prophylaxis Revenue by Region: 2018-2023
3.3.2 Global Venous Thromboembolism Prophylaxis Revenue by Region: 2024-2029
3.4 North America Venous Thromboembolism Prophylaxis Market Facts & Figures by Country
3.4.1 North America Venous Thromboembolism Prophylaxis Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Venous Thromboembolism Prophylaxis Sales by Country (2018-2029)
3.4.3 North America Venous Thromboembolism Prophylaxis Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Venous Thromboembolism Prophylaxis Market Facts & Figures by Country
3.5.1 Europe Venous Thromboembolism Prophylaxis Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Venous Thromboembolism Prophylaxis Sales by Country (2018-2029)
3.5.3 Europe Venous Thromboembolism Prophylaxis Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Venous Thromboembolism Prophylaxis Market Facts & Figures by Country
3.6.1 Asia Pacific Venous Thromboembolism Prophylaxis Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Venous Thromboembolism Prophylaxis Sales by Country (2018-2029)
3.6.3 Asia Pacific Venous Thromboembolism Prophylaxis Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Venous Thromboembolism Prophylaxis Market Facts & Figures by Country
3.7.1 Latin America Venous Thromboembolism Prophylaxis Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Venous Thromboembolism Prophylaxis Sales by Country (2018-2029)
3.7.3 Latin America Venous Thromboembolism Prophylaxis Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Venous Thromboembolism Prophylaxis Market Facts & Figures by Country
3.8.1 Middle East and Africa Venous Thromboembolism Prophylaxis Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Venous Thromboembolism Prophylaxis Sales by Country (2018-2029)
3.8.3 Middle East and Africa Venous Thromboembolism Prophylaxis Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Venous Thromboembolism Prophylaxis Sales by Type (2018-2029)
4.1.1 Global Venous Thromboembolism Prophylaxis Sales by Type (2018-2023)
4.1.2 Global Venous Thromboembolism Prophylaxis Sales by Type (2024-2029)
4.1.3 Global Venous Thromboembolism Prophylaxis Sales Market Share by Type (2018-2029)
4.2 Global Venous Thromboembolism Prophylaxis Revenue by Type (2018-2029)
4.2.1 Global Venous Thromboembolism Prophylaxis Revenue by Type (2018-2023)
4.2.2 Global Venous Thromboembolism Prophylaxis Revenue by Type (2024-2029)
4.2.3 Global Venous Thromboembolism Prophylaxis Revenue Market Share by Type (2018-2029)
4.3 Global Venous Thromboembolism Prophylaxis Price by Type (2018-2029)
5 Segment by Application
5.1 Global Venous Thromboembolism Prophylaxis Sales by Application (2018-2029)
5.1.1 Global Venous Thromboembolism Prophylaxis Sales by Application (2018-2023)
5.1.2 Global Venous Thromboembolism Prophylaxis Sales by Application (2024-2029)
5.1.3 Global Venous Thromboembolism Prophylaxis Sales Market Share by Application (2018-2029)
5.2 Global Venous Thromboembolism Prophylaxis Revenue by Application (2018-2029)
5.2.1 Global Venous Thromboembolism Prophylaxis Revenue by Application (2018-2023)
5.2.2 Global Venous Thromboembolism Prophylaxis Revenue by Application (2024-2029)
5.2.3 Global Venous Thromboembolism Prophylaxis Revenue Market Share by Application (2018-2029)
5.3 Global Venous Thromboembolism Prophylaxis Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Arjo
6.1.1 Arjo Corporation Information
6.1.2 Arjo Description and Business Overview
6.1.3 Arjo Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Arjo Venous Thromboembolism Prophylaxis Product Portfolio
6.1.5 Arjo Recent Developments/Updates
6.2 Encompass Group
6.2.1 Encompass Group Corporation Information
6.2.2 Encompass Group Description and Business Overview
6.2.3 Encompass Group Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Encompass Group Venous Thromboembolism Prophylaxis Product Portfolio
6.2.5 Encompass Group Recent Developments/Updates
6.3 Talley Group
6.3.1 Talley Group Corporation Information
6.3.2 Talley Group Description and Business Overview
6.3.3 Talley Group Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Talley Group Venous Thromboembolism Prophylaxis Product Portfolio
6.3.5 Talley Group Recent Developments/Updates
6.4 MEGO AFEK
6.4.1 MEGO AFEK Corporation Information
6.4.2 MEGO AFEK Description and Business Overview
6.4.3 MEGO AFEK Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2018-2023)
6.4.4 MEGO AFEK Venous Thromboembolism Prophylaxis Product Portfolio
6.4.5 MEGO AFEK Recent Developments/Updates
6.5 Zenith Technical Innovations
6.5.1 Zenith Technical Innovations Corporation Information
6.5.2 Zenith Technical Innovations Description and Business Overview
6.5.3 Zenith Technical Innovations Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Zenith Technical Innovations Venous Thromboembolism Prophylaxis Product Portfolio
6.5.5 Zenith Technical Innovations Recent Developments/Updates
6.6 Normatec
6.6.1 Normatec Corporation Information
6.6.2 Normatec Description and Business Overview
6.6.3 Normatec Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Normatec Venous Thromboembolism Prophylaxis Product Portfolio
6.6.5 Normatec Recent Developments/Updates
6.7 Bio Compression Systems
6.6.1 Bio Compression Systems Corporation Information
6.6.2 Bio Compression Systems Description and Business Overview
6.6.3 Bio Compression Systems Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bio Compression Systems Venous Thromboembolism Prophylaxis Product Portfolio
6.7.5 Bio Compression Systems Recent Developments/Updates
6.8 ThermoTek USA
6.8.1 ThermoTek USA Corporation Information
6.8.2 ThermoTek USA Description and Business Overview
6.8.3 ThermoTek USA Venous Thromboembolism Prophylaxis Sales, Revenue and Gross Margin (2018-2023)
6.8.4 ThermoTek USA Venous Thromboembolism Prophylaxis Product Portfolio
6.8.5 ThermoTek USA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Venous Thromboembolism Prophylaxis Industry Chain Analysis
7.2 Venous Thromboembolism Prophylaxis Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Venous Thromboembolism Prophylaxis Production Mode & Process
7.4 Venous Thromboembolism Prophylaxis Sales and Marketing
7.4.1 Venous Thromboembolism Prophylaxis Sales Channels
7.4.2 Venous Thromboembolism Prophylaxis Distributors
7.5 Venous Thromboembolism Prophylaxis Customers
8 Venous Thromboembolism Prophylaxis Market Dynamics
8.1 Venous Thromboembolism Prophylaxis Industry Trends
8.2 Venous Thromboembolism Prophylaxis Market Drivers
8.3 Venous Thromboembolism Prophylaxis Market Challenges
8.4 Venous Thromboembolism Prophylaxis Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer